Summary: Metabolites of arachidonic acid produced by P450 are interesting substances with prominent physiological functions. To elucidate the physiological function of P450, it is necessary to identify a speciˆc P450 in a particular tissue or organ and to characterize its catalytic activities. In this study, the expression of CYP2A1, 2B1, 2C23, 2J3, and 4F1 was investigated in liver, lung, kidney, spleen, heart, brain, and testis of rats by RT-PCR. Furthermore, arachidonic acid metabolism was investigated using the rat P450s described above and human CYP2A6, 2B6, 2C9, 2C18, 2C19, 2J2, and 4F2. Among the rat P450s, CYP2B1 and 2C23 e‹ciently produced EETs and CYP4F1 produced 19 W 20-HETE in abundace. CYP2B1 was speciˆcally expressed in the lung. CYP2C23 was detected in all tissues used in this study. CYP4F1 was expressed in the kidney as well as in the liver. Among the human P450s, CYP2C9 and 2C19 e‹ciently produced EETs. CYP4F2 produced 19 W 20-HETE. The catalytic properties of rat CYP2C23 were similar to those of human CYP2C9 and 2C19. The catalytic properties of CYP4F isoforms were also similar between humans and rats. A systematic analysis of P450 expression in various tissues and of its catalytic property may provide valuable information on the physiological roles of P450s in each tissue.
Introduction
Arachidonic acid is metabolized by cytochrome P450s (P450s) to many biologically active eicosanoids including epoxyeicosatrienoic acids (EETs) and hydroxyeicosatetraenoic acids (HETEs). This enzymatic pathway wasˆrst described in the liver, 1) however, it is now clear that arachidonic acid can be metabolized by P450s in many tissues including brain, kidney, lung, heart, and blood vessels.
2) Recent reports suggest that speciˆc P450s localize in each tissue and contribute to the regulation of homeostasis in tissue function. 3, 4) Furthermore, Yamazaki and Shimada 5) reported the possibility of interaction between drugs and endogenous substrates such as arachidonic acid. The P450s in the CYP2B, 2C, and 2J families are thought to be drug-metabolizing enzymes but are reported to produce EETs. 4, 6, 7) The EETs have four isomers, 5,6-EET, 8,9-EET, 11,12-EET, and 14,15-EET. In the brain, astrocytes produce 5,6-EET which is suggested to be a component of calcium in‰ux factor. 8) Cyp2j9 was isolated from mouse brain and is abundant in cerebellar Purkinje cells. 9) Cyp2j9 produced 19-HETE which inhibited the activity of P W Q-type Ca 2＋ channels. These channels are expressed preferentially in cerebellar Purkinje cells and are involved in triggering neurotransmitter release. In the kidney, EETs promote salt excretion in proximal tubules and have potent eŠects on renal vascular tone. For example, 5,6-EET was found to dilate isolated blood vessels and to inhibit sodium reabsorption and 12) and 20-HETE is a potent vasoconstrictor of isolated rat aorta. 13) In the lung, 11,12-EET causes signiˆcant changes in rat airway electrical parameters, suggesting that it is involved in the control of lung ‰uid and electrolyte transport. 14) 5,6-EET and 14,15-EET increase endothelial permeability by depletion of endoplasmic reticulum Ca 2＋ stores in rat lung. 15) CYP2J3 was isolated from a rat heart cDNA library. 16) Recombinant CYP2J3 produced 8,9-EET, 11,12-EET, and 14,15-EET. 11,12-EET improved the recovery of cardiac contractility with the addition of perfusate prior to global ischemia of the heart, suggesting that 11,12-EET plays an important functional role in the response of the heart to ischemia. 16) Thesê ndings indicate that P450s have much more speciˆc and complex physiological functions than are currently recognized. To clarify the physiological function of P450, it is necessary to identify a speciˆc P450 in a particular tissue or organ and to characterize its catalytic activities. As described above, metabolites of arachidonic acid are one of the most interesting substances which have prominent physiological functions. The aim of the present study was to compare the arachidonic acid metabolism of rat P450s with those of human P450s in the same gene family.
In this study, we investigated the expression ofˆve P450 isoforms (CYP2A1, 2B1, 2C23, 2J3, and 4F1) in liver, lung, kidney, spleen, heart, brain, and testis of rats. As described above, these P450s seem to play an important role in physiology in extrahepatic tissues. The metabolism of arachidonic acid by these rat P450s were compared with those of human P450s, CYP2A6, 2B6, 2C9, 2C18, 2C19, 2J2, and 4F2, expressed in insect cells using a baculovirus system.
Materials and Methods
Chemicals and P450s: Dilauroylphosphatidylcholine (DLPC) and arachidonic acid were obtained from Sigma Chemical Co. (St. Louis, MO). [1- 14 C]Arachidonic acid was purchased from New England Nuclear (Boston, MA). Human CYP2A6, 2B6, 2C9, 2C18, 2C19, 2J2, and 4F2 expressed by the Baculovirus system were obtained from Gentest (Wobum, MA). NADPH was from Oriental Yeast Co. (Tokyo, Japan). All other chemicals and solvents were obtained from Wako Pure Chemical Industries (Osaka, Japan). CYP2A1, 2B1, 2J3, and 4F1 were puriˆed from hepatic microsomes of Sprague-Dawley rats (Nippon Clea) as described previously. 17, 18) CYP2C23 was puriˆed from rat kidney microsomes. 19) Cytochrome b5 and NADPH-P450 reductase were puriˆed from rat liver microsomes as described previously. 17) Detection of P450 expression by RT-PCR: Total RNA was isolated from the frozen liver, lung, kidney, spleen, heart, brain, and testis of rats using Isogen (Nippon Gene, Toyama, Japan) according to the manufacturer's instructions. After treatment with DNase, total RNA was converted to cDNA by reversetranscription as described previously. 20) The cDNA produced was ampliˆed using the primers listed in Table 1 . PCR was done in a reaction mixture (50 mL) containing cDNA (0.1 mg), each primer (10 pmol), dNTP (0.2 mM), MgCl 2 (2.5 mM), and Ampli Taq Gold (Perkin-Elmer, Branchburg, NJ). PCR ampliˆcation was done for 30-40 cycles (949 C for 1 min, 569 C for 1 min, and 729 C for 2.5 min). We chose the maximum number of PCR cycles that can maintain the linearity of the ampliˆcation. The products were analyzed on a 2z agarose gel. The gels were stained with ethidium bromide, and visualized with UV.
Arachidonic acid metabolism: The metabolism of arachidonic acid by rat and human P450s was assayed 14 C]arachidonic acid by separation using HPLC with a reversed-phase column as described previously. 21, 22) The reaction mixture containing recombinant human P450 (50 pmol) expressed by the baculovirus system or puriˆed rat P450 (50 pmol) with cytochrome b5 (50 pmol), NADPH-P450 reductase (0.1 units), and DLPC (5 mg) was incubated with arachidonic acid (100 mM) and NADPH for 30 min (for recombinant human P450) or 15 min (for puriˆed rat P450) at 379 C. Metabolites were extracted and analyzed by HPLC. Activity of P450s was measured under conditions in which the metabolism was proportional to the P450 concentration and incubation time.
Results
Expression of P450 isoform mRNAs in various tissues: The expression of CYP2A1, 2B1, 2C23, 2J3 and 4F1 was investigated in liver, lung, kidney, spleen, heart, brain, and testis of rats by RT-PCR (Fig. 1) . CYP2A1 was expressed in liver, spleen, and testis. The amount of P450 in spleen is reported to be small. 23) It is interesting that CYP2A1, which may have a speciˆc function in the spleen, was detected. CYP2B1 was abundant in lung. The result is consistent with a previous report. 24) CYP2C23 was originally puriˆed from rat kidney 19) and detected in all tissues examined in this study. Its levels were high in the liver and the kidney. CYP2J3 wasˆrst puriˆed from the livers of starved rats. 25) In humans, its homologous P450 cDNA was isolated from heart. 26) In the present study, CYP2J3 was detected in abundance in the liver and in small amounts in the kidney and brain. In mice, a brain-dominant isoform, Cyp2j9, was reported.
9) CYP4F1 wasˆrst puried from rat liver and leukotriene v-hydroxylase. 17, 18) Its expression was detected in liver and kidney.
Metabolism of arachidonic acid by puriˆed rat P450s: Production of 5,6-EET, 8,9-EET, 11,12-EET, 14,15-EET, and 19 W 20-HETE from arachidonic acid was investigated in a reconstituted system including puriˆed rat P450s (Fig. 2) . CYP2A1 exhibited no activity toward arachidonic acid. CYP2B1 produced all metabolites detected in this study and produced 14,15-EET most e‹ciently. CYP2C23 e‹ciently produced EETs. 11,12-EET was produced most abundantly and CYP2C23 did not produce 5,6-EET. The results were consistent with a previous study. 22) CYP2J3 produced EETs but its levels of activity was low. In humans, CYP2J is reported to be an arachidonic acid epoxygenase. 26) CYP4F1 speciˆcally produced 19 W 20-HETE.
Metabolism of arachidonic acid by human P450s and comparison of their activities with those of rats P450s:
The metabolic activity of recombinant human P450s toward arachidonic acid are shown in Fig. 3 . CYP2A6 revealed almost no activity similar to rat CYP2A1. CYP2B6 produced small amounts of EETs although rat CYP2B1 had moderate activity. CYP2C9, 2C18, and CYP2C19 are typical drug-metabolizing isoforms in human liver. CYP2C18 had weak activity but CYP2C9 and 2C19 e‹ciently metabolized arachidonic acid to HETEs and EETs. CYP2C19 revealed the highest levels of activity of any of the human P450 isoforms used in this study. CYP2J2 is reported as an arachidonic acid epoxygenase and also produced EETs in this study. 26) Its activity was stronger than that of rat CYP2J2 but much weaker than that of CYP2C9 or CYP2C19. Like rat P450, CYP4F2 produced 19 W 20-HETE speciˆcally and e‹ciently.
Discussion
There are many reports dealing with the metabolism of arachidonic acid by P450s (reviewed in ref. 27 ). The physiological functions of EETs and 19-or 20-HETE among metabolites of arachidonic acid have been focused on. Choudhary et al. 23, 28) reported a systematic investigation of the expression of many P450 mRNAs in mouse and human tissues. In the present study, we investigated the tissue distribution of several P450s in rats and compared the activity of rat P450s to metabolize arachidonic acid with that of human P450s. Rat CYP2A1 and human CYP2A6 had little activity The y-axis indicates catalytic activity expressed as pmol of product W min W nmol of P450. EET, epoxyeicosatrienoic acid and HETE, hydroxyeicosatetraenoic acid toward arachidonic acid. CYP2A1 mRNA was expressed in liver, spleen, and testis. Rat CYP2B1 metabolized arachidonic acid to produce four EETs e‹ciently but human CYP2B6 did not. CYP2B1 mRNA is expressed speciˆcally in rat lung and reported to be present in airway epithelial cells including Clara cells. 29) CYP2B1 e‹ciently produced EETs which may play a role in regulating the volume and composition of airway surface liquids by modulating airway transepithelial transport. 30) CYP2C23 is highly expressed in rat kidney, where it is involved in regulating the biosynthesis of EETs. EETs contribute to integrated kidney function by directly aŠecting tubular transport processes and vascular tone. 3) In the present study, CYP2C23 mRNA was detected in abundance in rat kidney and was detected in all tissues tested. In humans, CYP2C9 was detected in the proximal tubules of the kidney 4) and distributed in many tissues although expression of CYP2C19 was detected in a limited tissue. 31) CYP2C9 produced 14,15-EET most e‹ciently and little 5,6-EET. CYP2C23 produced 11,12-EET most e‹ciently and did not 5,6-EET. 11,12-EET and 14,15-EET are found to have several physiological functions such as regulation of ion-transport and blood pressure. 32) Both CYP2C9 and CYP2C23 are major CYP2C forms in human and rat kidney, respectively. 4, 33) In hypertensive rats, expression of CYP2C23 in renal tubules was decreased, concomitant with the decrease in EET production, suggesting that these P450s play important role in kidney functions. 34) CYP2C18 and CYP2C19 had diŠerent catalytic properties from CYP2C9. CYP2C18 is expressed in human kidney but CYP2C19 is not. 31) CYP2C18 had little activity toward arachidonic acid. CYP2C19 exhibited strong activity and produced The y-axis indicates catalytic activity expressed as pmol of product W min W nmol of P450. EET, epoxyeicosatrienoic acid and HETE, hydroxyeicosatetraenoic acid 19 W 20-HETE in abundance. CYP2C19 also produced EETs, especially 8,9-EET. Weˆrst isolated CYP2J3 from rat liver. 25) CYP2J3 was thought to be an epoxygenase of arachidonic acid like CYP2C23 but produced little EET. In humans, CYP2J2 cDNA waŝ rst isolated from a heart library. In the present study, CYP2J3 was expressed in abundance in rat liver, followed by kidney and brain and not detected in heart. Recently, a brain-speciˆc CYP2J form was isolated from mice. 9) It may have an important physiological role in the brain. CYP4F1 was dominantly expressed in liver and kidney, especially kidney. CYP4F1 speciˆcally and e‹ciently produced 19 W 20-HETE. Human CYP4F2 had similar catalytic properties. Lasker et al. 11) found that CYP4F2 was present in proximal tubules of human kidney, and suggested that CYP4F2 partakes in pivotal renal functions, including the regulation of the salt and water balance.
A systematic analysis of the expression of P450 in various tissues may provide valuable information on the physiological roles of P450s in each tissue. Furthermore, a systematic comparison of human P450s with rat P450s may prove helpful in predicting the physiological functions of human P450s in each tissue.
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